Cargando…
Expression and Clinical Relevance of SOX9 in Gastric Cancer
Gastric cancer is one of the most frequent tumours and the third leading cause of cancer-related death worldwide. The investigation of new biomarkers that can predict patient outcome more accurately and allow better treatment and follow-up decisions is of crucial importance. SOX9 (sex-determining re...
Autores principales: | Mesquita, Patrícia, Freire, Ana F., Lopes, Nair, Gomes, Rosa, Azevedo, Daniela, Barros, Rita, Pereira, Bruno, Cavadas, Bruno, Pópulo, Helena, Boaventura, Paula, David, Leonor, Pereira, Luísa, Almeida, Raquel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6589301/ https://www.ncbi.nlm.nih.gov/pubmed/31275454 http://dx.doi.org/10.1155/2019/8267021 |
Ejemplares similares
-
A SOX2 Reporter System Identifies Gastric Cancer Stem-Like Cells Sensitive to Monensin
por: Pádua, Diana, et al.
Publicado: (2020) -
Dynamics of SOX2 and CDX2 Expression in Barrett's Mucosa
por: Barros, Rita, et al.
Publicado: (2016) -
Prognostic significance of MUC2, CDX2 and SOX2 in stage II colorectal cancer patients
por: Ribeirinho-Soares, Sara, et al.
Publicado: (2021) -
Immunohistochemical molecular phenotypes of gastric cancer based on SOX2 and CDX2 predict patient outcome
por: Camilo, Vânia, et al.
Publicado: (2014) -
Modified-Chitosan/siRNA Nanoparticles Downregulate Cellular CDX2 Expression and Cross the Gastric Mucus Barrier
por: Sadio, Ana, et al.
Publicado: (2014)